Ensemble and deep learning models for early disease detection from clinical data

Source article: Artificial Intelligence Models for Early Disease Detection Using Clinical Data

In a variety of chronic and acute diseases, earlier detection of disease is a major determinant of better patient outcomes, better treatment costs savings and reduced mortality.The current diagnostic process, mostly manual, manual interpretation of clinical data, is limited by the capacity of the human mind, by inter-observer variability and by the amount of data produced by modern healthcare systems.Artificial Intelligence (AI) that leverages machine learning (ML) and deep learning (DL) capabilities has become…

By the Truvace deskOctober 15, 20262 min read1 sourcePeer-reviewedTRV-2026-1479· cite & verify

Trace impact readingContested

P 68

Both sides are scored from claims and sources, not community votes.

G 71

In brief

The paper reviews machine learning and deep learning classifiers for spotting disease early from laboratory results, electronic health records, vital signs, and medical image metadata. It compares models from logistic regression to LSTM networks on accuracy, precision, recall, F1-score, and AUC-ROC, and lays out a workflow from data acquisition to interpretability. The workflow is illustrated through simulated experiments.

Earlier detection is described as a major determinant of better outcomes, lower treatment costs, and reduced mortality, and manual interpretation is limited by human capacity and inter-observer variability. The accuracy advantage of XGBoost and CNN is reported only in simulation, and the paper itself flags privacy, class imbalance, explainability, and clinical integration as open problems.

Main points

Data sources covered include laboratory results, electronic health records, vital signs, and medical image metadata.
Models compared include Logistic Regression, SVMs, Random Forests, gradient boosting, ANNs, CNNs, and LSTMs.
Performance was judged on accuracy, precision, recall, F1-score, and AUC-ROC.
XGBoost and CNN were more accurate than traditional statistical models but less interpretable and more resource-hungry.
Future directions named are federated learning, explainable AI, and multimodal data fusion.

The gain

In simulated experiments, ensemble and deep learning models, especially XGBoost and CNN, forecast disease more accurately than traditional statistical models on clinical data.

The problem

The same higher-performing ensemble and deep learning models are less interpretable and more resource-demanding than traditional statistical models, which complicates their use in clinical settings.

The rundown

The authors argue that current diagnosis relies largely on manual interpretation of clinical data, which is constrained by human capacity, inter-observer variability, and the volume of data modern healthcare systems generate. They present AI as a way to find patterns in large, heterogeneous, high-dimensional datasets.

The proposed pipeline covers data acquisition, preprocessing, feature engineering, model training, validation, and interpretability, and is demonstrated with simulated experiments rather than reported patient outcomes.

Beyond performance, the paper highlights data privacy, class imbalance, model explainability, and clinical integration as obstacles, and suggests federated learning, explainable AI, and multimodal data fusion as research directions.

What this doesn’t fix

The performance findings come from simulated experiments rather than real-world clinical deployment, and the paper notes unresolved issues with privacy, class imbalance, explainability, and clinical integration.